rs1403688955

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_018993.4(RIN2):​c.-36-2841G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000129 in 1,545,690 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000067 ( 0 hom., cov: 29)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

RIN2
NM_018993.4 intron

Scores

15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0950

Publications

0 publications found
Variant links:
Genes affected
RIN2 (HGNC:18750): (Ras and Rab interactor 2) The RAB5 protein is a small GTPase involved in membrane trafficking in the early endocytic pathway. The protein encoded by this gene binds the GTP-bound form of the RAB5 protein preferentially over the GDP-bound form, and functions as a guanine nucleotide exchange factor for RAB5. The encoded protein is found primarily as a tetramer in the cytoplasm and does not bind other members of the RAB family. Mutations in this gene cause macrocephaly alopecia cutis laxa and scoliosis (MACS) syndrome, an elastic tissue disorder, as well as the related connective tissue disorder, RIN2 syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2011]
RIN2 Gene-Disease associations (from GenCC):
  • RIN2 syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Orphanet, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06979102).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RIN2NM_018993.4 linkc.-36-2841G>C intron_variant Intron 2 of 12 ENST00000255006.12 NP_061866.1 Q8WYP3-1A1A4T0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RIN2ENST00000255006.12 linkc.-36-2841G>C intron_variant Intron 2 of 12 2 NM_018993.4 ENSP00000255006.7 Q8WYP3-1
RIN2ENST00000648440.1 linkc.-92G>C 5_prime_UTR_variant Exon 1 of 12 ENSP00000498085.1 Q8WYP3-1
RIN2ENST00000432334.2 linkn.537-2841G>C intron_variant Intron 3 of 3 4
RIN2ENST00000648165.1 linkn.618-2841G>C intron_variant Intron 3 of 3

Frequencies

GnomAD3 genomes
AF:
0.00000673
AC:
1
AN:
148696
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000203
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000199
AC:
3
AN:
150648
AF XY:
0.0000124
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000280
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
7.16e-7
AC:
1
AN:
1396994
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
689028
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31490
American (AMR)
AF:
0.00
AC:
0
AN:
35602
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25118
East Asian (EAS)
AF:
0.0000281
AC:
1
AN:
35644
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79162
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48308
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5694
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1077942
Other (OTH)
AF:
0.00
AC:
0
AN:
58034
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000673
AC:
1
AN:
148696
Hom.:
0
Cov.:
29
AF XY:
0.0000138
AC XY:
1
AN XY:
72276
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40140
American (AMR)
AF:
0.00
AC:
0
AN:
14602
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3454
East Asian (EAS)
AF:
0.000203
AC:
1
AN:
4916
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4698
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9968
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
306
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67662
Other (OTH)
AF:
0.00
AC:
0
AN:
2040
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Oct 20, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine with threonine at codon 19 of the RIN2 protein (p.Arg19Thr). The RIN2 gene has multiple clinically relevant transcripts. This variant occurs in alternate transcript NM_001242581.1, and corresponds to NM_018993.3 in the primary transcript. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with RIN2-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
3.1
DANN
Benign
0.90
Eigen
Benign
-0.75
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.079
N
LIST_S2
Benign
0.37
T
M_CAP
Benign
0.0073
T
MetaRNN
Benign
0.070
T
MetaSVM
Benign
-1.0
T
PhyloP100
0.095
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.080
N
REVEL
Benign
0.027
Sift
Benign
0.32
T
Vest4
0.19
MutPred
0.47
Loss of MoRF binding (P = 0.0277);
MVP
0.23
MPC
0.49
ClinPred
0.30
T
GERP RS
-0.14
PromoterAI
-0.024
Neutral
gMVP
0.058

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1403688955; hg19: chr20-19867369; COSMIC: COSV54791337; COSMIC: COSV54791337; API